EI
TYRA icon

Ellevest Inc’s Tyra Biosciences TYRA Stock Holding History

Ellevest Inc’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27
Closed – – 1959
2022
Q3 		$0 Buy
+27
New +$247 ﹤0.01% 1865

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ellevest Inc's TYRA Position: Q4 2022 in Review

Ellevest Inc sold out of Tyra Biosciences (TYRA) in Q4 2022, closing a stake of 27 shares.

Ellevest Inc first reported a position in TYRA in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 46 funds tracked by Wall St. Rank hold TYRA as of Q4 2022.

  • Ellevest Inc reported no remaining Tyra Biosciences position as of Q4 2022 after selling out during the quarter.
  • Ellevest Inc sold 27 Tyra Biosciences shares in Q4 2022.
  • Ellevest Inc first reported a position in Tyra Biosciences in Q3 2022 and held it in 1 quarter.
  • Ellevest Inc's Tyra Biosciences position peaked at $0 in Q3 2022.
  • 46 funds tracked by Wall St. Rank held Tyra Biosciences as of Q4 2022.

Based on Ellevest Inc's 13F filing for Q4 2022, filed 3 Feb 2023.